Growth hormone and reproduction: lessons learned from animal models and clinical trials
Growth Hormone (GH) has been considered as a therapeutic option to increase the number
of growing follicles during Assisted Reproductive Technology (ART) for more than 30 years …
of growing follicles during Assisted Reproductive Technology (ART) for more than 30 years …
Regulation of ovarian function by growth hormone: potential intervention of ovarian aging
L Han, H Tian, X Guo, L Zhang - Frontiers in Endocrinology, 2023 - frontiersin.org
Growth hormone (GH) is mainly secreted by eosinophils of anterior pituitary gland. GH plays
an important role in regulating the growth and development of many tissues and cells, so it is …
an important role in regulating the growth and development of many tissues and cells, so it is …
[HTML][HTML] Growth hormone supplementation may improve the pregnancy rate and endometrial receptivity among women aged more than 40 years undergoing in vitro …
KC Lan, PY Lin, YC Chang, YJ Chen, YR Tsai… - biomedical …, 2019 - Elsevier
Background Growth hormone (GH) supplements have been shown to improve pregnancy
and live-birth rates, suggesting that GH has a beneficial effect on oocyte quality. However …
and live-birth rates, suggesting that GH has a beneficial effect on oocyte quality. However …
[HTML][HTML] Effects of adjuvant growth hormone therapy on poor ovarian responders in assisted reproductive technology
S Zafardoust, S Ansaripor, A Karimi, H Hosseinirad… - Maedica, 2022 - ncbi.nlm.nih.gov
Objective: The present study aimed to evaluate the effect of adjuvant growth hormone (GH)
therapy in antagonist protocol aiming to improve ovarian response and clinical outcomes of …
therapy in antagonist protocol aiming to improve ovarian response and clinical outcomes of …
The potential role of growth hormone on the endometrium in assisted reproductive technology
FT Liu, Z Wu, J Yan, RJ Norman, R Li - Frontiers in Endocrinology, 2020 - frontiersin.org
Growth hormone (GH) has been considered as an adjuvant treatment in human assisted
reproductive technology (ART) for several years. Its action was largely attributed to an …
reproductive technology (ART) for several years. Its action was largely attributed to an …
Growth hormone cotreatment for low-prognosis patients according to the POSEIDON criteria
X Liu, J Xu, L Bi, P Liu, X Jiao - Frontiers in Endocrinology, 2021 - frontiersin.org
Background Poor ovarian response (POR) remains one of the most challenging conditions
in assisted reproduction technology. Previous studies seemed to indicate that growth …
in assisted reproduction technology. Previous studies seemed to indicate that growth …
The effects of intraovarian injection of autologous menstrual blood-derived mesenchymal stromal cells on pregnancy outcomes in women with poor ovarian response
S Zafardoust, S Kazemnejad, M Fathi-Kazerooni… - Stem Cell Research & …, 2023 - Springer
Background Assisted reproduction faces a significant obstacle in the form of poor ovarian
response (POR) to controlled ovarian stimulation. To address this challenge, mesenchymal …
response (POR) to controlled ovarian stimulation. To address this challenge, mesenchymal …
[HTML][HTML] Stimulation for low responder patients: adjuvants during stimulation
RJ Hart - Fertility and Sterility, 2022 - Elsevier
Growth hormone, letrozole, and clomiphene citrate do not have US Food and Drug
Administration approval for their use in in vitro fertilization (IVF) cycles. However, despite this …
Administration approval for their use in in vitro fertilization (IVF) cycles. However, despite this …
Outcomes of poor responders following growth hormone co-treatment with IVF/ICSI mild stimulation protocol: a retrospective cohort study
K Chu, W Pang, N Sun, Q Zhang, W Li - Archives of Gynecology and …, 2018 - Springer
Purpose No research has studied the effect of GH co-treatment in mild stimulation protocol
for poor responders. We therefore conducted this retrospective analysis to assess the …
for poor responders. We therefore conducted this retrospective analysis to assess the …
Follicular fluid growth factors and interleukin profiling as potential predictors of IVF outcomes
B Molka, B Gwladys, B Dorian, M Lucie… - Frontiers in …, 2022 - frontiersin.org
Growth hormone (GH) has gained attention as an anti-aging compound enhancing oocyte
quality. In fact, GH is known to activate intrafollicular metabolic events for oocyte maturation …
quality. In fact, GH is known to activate intrafollicular metabolic events for oocyte maturation …